| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 44.94B | 48.51B | 53.54B | 50.73B | 52.76B |
| Gross Profit | 22.51B | 24.44B | 26.96B | 24.31B | 27.25B |
| EBITDA | 11.75B | 13.70B | 15.63B | 13.98B | 16.56B |
| Net Income | 3.81B | 5.64B | 852.00M | 7.15B | 7.38B |
Balance Sheet | |||||
| Total Assets | 114.99B | 114.78B | 126.76B | 124.85B | 129.61B |
| Cash, Cash Equivalents and Short-Term Investments | 22.56B | 22.27B | 24.72B | 19.71B | 15.98B |
| Total Debt | 2.16B | 1.58B | 331.00M | 2.12B | 1.58B |
| Total Liabilities | 34.60B | 35.25B | 42.04B | 40.30B | 43.21B |
| Stockholders Equity | 79.87B | 79.10B | 84.22B | 84.01B | 85.86B |
Cash Flow | |||||
| Free Cash Flow | 5.02B | 5.86B | 10.28B | 8.48B | 10.08B |
| Operating Cash Flow | 7.41B | 8.81B | 14.18B | 12.35B | 14.79B |
| Investing Cash Flow | -2.53B | -3.18B | -3.50B | -3.45B | -5.68B |
| Financing Cash Flow | -5.75B | -7.01B | -4.86B | -3.92B | -3.61B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | HK$541.85B | 30.61 | 42.43% | 1.73% | 22.57% | 31.01% | |
76 Outperform | HK$455.76M | 6.04 | 10.82% | 4.07% | 3.68% | ― | |
71 Outperform | HK$85.80B | 8.15 | 14.96% | 4.69% | 1.61% | 6.76% | |
70 Outperform | HK$84.93B | 23.27 | 1.45% | 3.42% | -1.89% | -30.46% | |
63 Neutral | HK$101.65B | 26.31 | 8.50% | 5.59% | -7.82% | -32.91% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |